UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000050299
Receipt number R000057273
Scientific Title Observational study on sleep-related indicators.
Date of disclosure of the study information 2023/02/13
Last modified on 2023/12/25 15:12:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study on sleep-related indicators.

Acronym

Observational study on sleep-related indicators.

Scientific Title

Observational study on sleep-related indicators.

Scientific Title:Acronym

Observational study on sleep-related indicators.

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine the relevance of sleep-related indicators.

Basic objectives2

Others

Basic objectives -Others

Observational study on sleep-related indicators.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Objective indicators and subjective assessments of sleep.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

(1)Healthy male and female who are at least 20 years old at the time of consent and less than 65 years old at the end of the study.
(2)Subjects who can make self-judgment and voluntarily gave informed consent.

Key exclusion criteria

(1) Subjects who have been diagnosed with sleep disorders.
(2) Subjects taking medications (e.g., sleep aids) that are thought to have the potential to affect the study and whose use cannot be restricted during the study period.
(3) Subjects who will be in a time zone during the study period for business or travel.
(4) Subjects who have allergic to metal.
(5) Females in pregnancy, lactation and scheduled pregnancy period.
(6) Subjects being under other clinical tests, or partook in those within the past four weeks.
(7) Subjects who meet any of the following:
(a) suffering from heart, liver, or kidney disease (including complications of other diseases)
(b) having a history of cardiovascular disease
(c) diabetes

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Hisako
Middle name
Last name Minami

Organization

Suntory beverage & Food limited

Division name

Development & Designed Department

Zip code

211-0067

Address

13-2 Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa, JAPAN

TEL

050-3182-6161

Email

Hisako_Nakamura@suntory.co.jp


Public contact

Name of contact person

1st name Megumi
Middle name
Last name Endo

Organization

Suntory beverage & Food limited

Division name

Development & Designed Department

Zip code

211-0067

Address

13-2 Imaikami-cho, Nakahara-ku, Kawasaki, Kanagawa, JAPAN

TEL

050-3182-5680

Homepage URL


Email

Megumi_Endo@suntory.co.jp


Sponsor or person

Institute

Suntory beverage & Food limited

Institute

Department

Personal name



Funding Source

Organization

Suntory beverage & Food limited

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Mibyou Research Ethics Review Committee

Address

2-18-4 Kandamisakicho,Chiyoda-ku, Tokyo

Tel

03-6272-9163

Email

renraku@npo-mibyou.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 02 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 01 Month 27 Day

Date of IRB

2023 Year 01 Month 25 Day

Anticipated trial start date

2023 Year 02 Month 13 Day

Last follow-up date

2023 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not applicable


Management information

Registered date

2023 Year 02 Month 10 Day

Last modified on

2023 Year 12 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000057273


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name